Platform trials for rare cancers-A complex innovation to accelerate knowledge
Neurooncol Pract
.
2024 May 24;11(4):365-366.
doi: 10.1093/nop/npae035.
eCollection 2024 Aug.
Authors
Peter Hau
1
,
Michael C Frühwald
2
Affiliations
1
Department of Neurology-NeuroOncology and Wilhelm Sander NeuroOncology, University Hospital Regensburg, Regensburg, Germany.
2
University Hospital Augsburg, Pediatrics and Adolescent Medicine, Augsburg, Germany.
PMID:
39006529
PMCID:
PMC11241356
(available on
2025-05-24
)
DOI:
10.1093/nop/npae035
No abstract available
Publication types
Editorial